Account

The Medical and Surgical Practice of NaProTECHNOLOGY, 813-824, 2004

Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy

Thomas W Hilgers

Author affiliations
  • Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Read at source

Abstract

Management of pregnancies complicated by lethal fetal anomalies is addressed within an ethical framework that provides perinatal palliative care, parental support, and medical management without recourse to induced abortion. The chapter outlines clinical protocols for continuing care that respect fetal life while attending to maternal physical and psychological wellbeing through delivery and bereavement.

Topics

prenatal genetic screening accuracyTriple Test false positive rateinvasive prenatal diagnosis fetal loss riskPerinatal Hospice lethal fetal anomalypreimplantation genetic diagnosis embryo losslife-affirming prenatal care
how accurate is the Triple Test for Down syndrome, false positive rate of prenatal screening, miscarriage risk of amniocentesis vs CVS, what is perinatal hospice for lethal fetal anomaly, does preimplantation genetic diagnosis improve IVF success, chorionic villus sampling reliability vs amniocentesis, pro-life approach to prenatal diagnosis, what to do after positive Down syndrome screen

Cite this article

Hilgers, T. W. (2004). Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy. The Medical and Surgical Practice of NaProTECHNOLOGY, 813-824.

Related articles

Fertility AwarenessScientific FoundationsBiophysical Properties and Mucus TypingHormonal and Ultrasound Correlation

Chapter 15: Scientific Foundations of the CrMS

Hilgers TW, 2004The Medical and Surgical Practice of NaProTECHNOLOGY

The CREIGHTON MODEL FertilityCare System (CrMS) rests on a decades-long body of research demonstrating that cervical mucus functions as a physiologically regulated biological valve, opening predictably at the periovulatory estrogen rise and closing in the post-Peak phase. Chapter 15 of Hilgers (2004) synthesizes hormonal, ultrasound, cytologic, and biophysical evidence to establish that a woman's external observation of her Peak Day reliably identifies the fertile window, and documents the system's effectiveness data for both achieving and avoiding pregnancy across a five-study meta-analysis of nearly 1,900 couples.

PCOSEpidemiology and PrevalenceMetabolic ReframeDefective Ovulatory Events

Chapter 43: Polycystic Ovarian Disease

Hilgers TW, 2004The Medical and Surgical Practice of NaProTECHNOLOGY

PCOS (polycystic ovary syndrome), increasingly designated PMOS (polycystic metabolic ovary syndrome) to reflect its metabolic complexity, is far more prevalent than its classic presentation suggests, affecting roughly six percent of reproductive-age women and carrying systemic consequences well beyond fertility disruption. This chapter from the foundational NaProTECHNOLOGY textbook maps the hormonal architecture of the condition, its ovulatory defect patterns, its frequent co-occurrence with endometriosis, and the restorative surgical and cycle-tracking approaches developed at the Pope Paul VI Institute.

Learn

Resources

Tools

Help

Candid Platinum Transparency 2026

RRM Academy is a 501(c)(3) nonprofit providing free and low-cost education in restorative reproductive medicine for patients and healthcare professionals.

This site is an educational resource and does not provide medical advice. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare provider for diagnosis and treatment.

© 2026 RRM Academy · All Rights Reserved

Restorative Reproductive Medicine Foundation Inc. · 3401 Hartzdale Dr, Ste 103B PMB 3518, Camp Hill, PA 17011 · EIN: 93-4594315
Sitemap AI Instructions Developers Terms of Use Medical Disclaimer Privacy Policy